July 15th 2025, 1:50pm
By Amrita Krishnan, MD
Panelists discuss the multifaceted diagnostic process for multiple myeloma, emphasizing the integration of blood tests, genetic and imaging assessments, and patient education to guide personalized treatment planning and enhance patient engagement in care.
July 15th 2025, 1:43pm
The program emphasized the importance of incorporating patient and caregiver perspectives alongside clinical expertise to support personalized, empathetic care and shared decision-making in managing the diverse and complex challenges of multiple myeloma.
July 15th 2025, 1:00pm
By Dr. Paolo Tarantino
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
July 14th 2025, 9:00pm
By Linda Cohen
I’m in remission from small lymphocytic lymphoma and off treatment, savoring this break while learning to live with the uncertainty that still lingers.
July 14th 2025, 8:00pm
By Dr. Erika Hamilton
Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change care for patients in the future.
July 14th 2025, 7:00pm
By Spencer Feldman
Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, according to Dr. Christina Poh.
July 14th 2025, 5:00pm
By Bonnie Annis
A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.
July 14th 2025, 4:00pm
By Ryan Scott
In a candid interview with CURE, Terry Gillespie reflects on how her definition of survivorship has evolved from her lung cancer diagnosis to present day.
July 14th 2025, 3:00pm
A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.
July 14th 2025, 1:00pm
By Dr. Breelyn Wilky
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
July 13th 2025, 6:00pm
By Andy Winnegar
During treatment for chronic lymphocytic leukemia and autoimmune anemia, I found relief and encouragement in a caring conversation with my oncology nurse.
July 13th 2025, 2:00pm
Dr. Lorenzo Cohen and Alison Jefferies discuss small yet meaningful changes that patients can make to their home environment to foster a sense of wellness.
July 12th 2025, 6:00pm
By Dr. Christine Poh
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
July 12th 2025, 2:00pm
Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will benefit from intensified treatment.
July 11th 2025, 9:00pm
By Sue McCarthy
I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive changes in my life.
Treating EHE: What Are Your Options?
FDA Approves Application for ABT-301 in Metastatic Colorectal Cancer
Why Art Was Good Medicine for Me After a Breast Cancer Diagnosis
Revolutionizing CAR T-Cell Therapy to Improve Patient Access